Trial intelligence / Profile preview

Vitamin D Supplementation in Women with Prior GDM and Vitamin D Deficiency

NCT03138616Phase 4Unknown

Sponsor
Shanghai General Hospital
Start
Nov 2016
Primary completion
Dec 2018
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 4, randomised, open-label trial of vitamin d in Vitamin D deficiency (VDD) and gestational diabetes mellitus (GDM) (4 arms), sponsored by Shanghai General Hospital. Primary endpoint: Change in glucose metabolism at 9 months. Status: unknown.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)gestational diabetes mellitus (GDM)

Beyond the preview

Go deeper on NCT03138616.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03138616.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call